Page 5 - Emergent Biosolution News Today

Leqembi’s manufacturers estimate the drug will be available by Jan. 23 and have priced the biweekly infusion at $26,500 annually.

This Week in Washington: All Efforts Are on Funding the Government Through the Rest of the Fiscal Year...

By spring, a drug used to reverse opioid overdoses may become available at your local pharmacy without a prescription.

The CDC could endorse Covid-19 shots updated to target two Omicron subvariants as soon as today for children under 6.

The Coronavirus Crisis committee lays out 30 recommendations for protecting the country during future pandemics.

(The Center Square) – The U.S. Food and Drug Administration accepted Emergent BioSolutions request to review its supplemental New Drug Application for the NARCAN® Nasal Spray to be sold as an over-the-counter emergency treatment for known or suspected opioid overdose, the company said Tuesday.

(The Center Square) – The U.S. Food and Drug Administration accepted Emergent BioSolutions request to review its supplemental New Drug Application for the NARCAN® Nasal Spray to be sold as

Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff

Worries about the monkeypox outbreak have driven Emergent's shares higher.

The government will expand access to and increase supply of two different formulations to contain the infection